K-numberK252649
Device nameTAP2D
ApplicantNano-X Imaging , Ltd.
Product codeIZF
Device classClass II
Decision dateFeb 2, 2026
DecisionSubstantially Equivalent
Regulation892.1740
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

TAP2D is a cloud-based software accessory for Nanox.ARC X and Nanox.ARC tomosynthesis systems that provides a supplemental enhanced 2D view image in DICOM format extracted from the acquired DTS study. It is intended to assist radiologists when evaluating diagnostic tomosynthesis studies by presenting an enhanced, high-contrast single 2D projection image alongside the diagnostic DTS series without altering the original data.

Technological characteristics

TAP2D is a software-only post-processing module (SaMD) deployed in Nanox.CLOUD infrastructure with no image acquisition capability, user interface, or manual activation required. It differs from the predicate Nanox.ARC X hardware-based acquisition system by operating automatically and producing only a supplemental 2D output rather than controlling hardware, but both use the same cloud processing location and DICOM format.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

TAP2D is substantially equivalent to Nanox.ARC X because it functions as an automatic post-processing accessory that produces a supplemental output from existing predicate device data without altering the predicate's functionality, raw data, or clinical performance. Both devices operate within the same clinical scope and workflow; TAP2D introduces no new clinical claims, safety concerns, or effectiveness questions, as confirmed by software verification, system performance testing, image quality assessment, and independent radiologist clinical validation.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →